Artal Group S.A. - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 12, 2026, for the 2025 Q4 period, Artal Group S.A. held in its portfolio 2 assets valued at $714,631,486 (i.e. $714.63M).

The most valuable assets in the portfolio included: Cava Group Inc ($558.02M), and Lexicon Pharmaceuticals Inc ($156.61M),

The chart below shows the top 2 valuable assets, and the table below shows the top 2 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Artal Group S.A. Portfolio

Cava Group Inc

Lexicon Pharmaceuticals Inc

Artal Group S.A. - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
Cava Group Inc	9507990	558023933	COM
Lexicon Pharmaceuticals Inc	136180481	156607553	COM NEW